SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-08-000043
Filing Date
2008-01-28
Accepted
2008-01-28 16:57:00
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 angcorgssc13g.htm SC 13G 120688
  Complete submission text file 0000898432-08-000043.txt   122922
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 650 GATEWAY BOULEVARD -- SOUTH SAN FRANCISCO CA 94080 6506249600
ANESIVA, INC. (Subject) CIK: 0001131517 (see all company filings)

IRS No.: 770503399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79795 | Film No.: 08554744
SIC: 2834 Pharmaceutical Preparations